Core Viewpoint - Halper Sadeh LLC is investigating potential breaches of fiduciary duties by certain officers and directors of Dentsply Sirona Inc., encouraging shareholders to contact the firm regarding their rights and possible corporate governance reforms [1]. Group 1: Investigation and Shareholder Rights - The law firm is looking into whether Dentsply Sirona's management has acted against the interests of shareholders [1]. - Long-term shareholders may seek various forms of relief, including corporate governance reforms and financial incentives [1]. - Shareholder involvement is emphasized as a means to improve company policies and enhance shareholder value [1]. Group 2: Legal Representation and Fees - Halper Sadeh LLC operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [1]. - The firm has a history of representing investors globally who have experienced securities fraud and corporate misconduct [1]. - The attorneys at Halper Sadeh LLC have successfully implemented corporate reforms and recovered significant amounts for defrauded investors [1].

Core Viewpoint - A securities fraud class action lawsuit has been filed against NuScale Power Corporation, alleging material misstatements regarding its commercialization strategy for nuclear power generation projects [1] Summary by Relevant Sections Lawsuit Details - The lawsuit is filed on behalf of investors who purchased NuScale Class A common stock between May 13, 2025, and November 6, 2025 [1] - The deadline for investors to seek lead plaintiff status is April 20, 2026 [1] - The case is filed in the United States District Court for the District of Oregon, titled Truedson v. NuScale Power Corporation, et al, Case No. 3:26-cv-00328 (D. Or.) [1] Allegations - The complaint alleges that NuScale made false or misleading statements and failed to disclose that ENTRA1 Energy LLC had no significant experience in building or operating nuclear power projects [1] - It is claimed that NuScale entrusted its commercialization and deployment of its power module to ENTRA1, which lacked relevant experience [1] - The lawsuit also states that the qualifications attributed to ENTRA1 were actually related to the Habboush Group, another entity without significant nuclear experience [1] - As a result, NuScale's commercialization strategy faced undisclosed risks of failure, delays, and regulatory challenges [1] Financial Impact - On November 6, 2025, NuScale reported a significant increase in general and administrative expenses, which rose over 3,000% to $519 million from $17 million in the previous year [1] - This increase was largely due to a $495 million payment to ENTRA1 for a TVA agreement [1] - Consequently, NuScale's quarterly net loss surged to $532 million, compared to $46 million in the prior year [1] - Following this announcement, NuScale's stock price dropped by $5.45 per share, or approximately 14.4%, closing at $32.46 on November 6, 2025 [1] Investor Actions - Investors are advised to retain counsel or contact Kessler Topaz Meltzer & Check, LLP for a free case evaluation [1] - They can also file to be lead plaintiff by the April 20, 2026 deadline [1] - The lead plaintiff will represent the class in directing the litigation and selecting counsel [1]

Core Viewpoint - Omnicom has announced the pricing of public offerings for senior notes totaling $1.7 billion in the U.S. and €600 million in Europe, aimed at refinancing existing debt and supporting general corporate purposes [1]. USD Notes Offering - The USD Notes consist of three tranches: $600 million of 5.300% Senior Notes due 2036, $700 million of 5.000% Senior Notes due 2033, and $400 million of 4.200% Senior Notes due 2029 [1]. - The offerings are expected to close on March 2, 2026, pending customary closing conditions [1]. - The net proceeds will be used to repay $1.4 billion of 3.600% Senior Notes due April 15, 2026, and for general corporate purposes, including working capital, acquisitions, and debt refinancing [1]. Euro Notes Offering - The Euro Notes offering includes €600 million of 3.850% Senior Notes due May 2, 2034, fully guaranteed by Omnicom [1]. - The Euro Notes will rank equally with existing and future unsecured senior indebtedness [1]. - An application will be made for the Euro Notes to be listed on The New York Stock Exchange, subject to approval [1]. Underwriters - Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. are joint global coordinators and book-running managers for the USD Notes offering [1]. - Citigroup Global Markets Limited and Deutsche Bank AG, London Branch are joint global coordinators for the Euro Notes offering [1].

Core Insights - Genomma Lab Internacional reported a challenging year in 2025, with like-for-like sales declining by -4.3% due to a weak summer beverage season and a softer consumption environment in Mexico [1] - The company achieved a year-end EBITDA margin of 23.4%, demonstrating strong business fundamentals despite topline pressure [1] - Genomma Lab anticipates that growth initiatives will gain traction in the second half of 2026, supporting a recovery in operational leverage [1] Financial Performance Summary - Q4 2025 net sales decreased by -13.9% to MXN 4,017 million, while full-year net sales fell by -5.7% to MXN 17,541 million [1] - Gross profit for Q4 2025 was MXN 2,449 million, a decline of -16.7% year-over-year, with a full-year gross profit of MXN 11,022 million, down -7.6% [1] - Net income from continuous operations decreased by -23.1% for the full year 2025, totaling MXN 1,607 million, and declined by -13.0% in Q4 2025 to MXN 319 million [1] Operational Highlights - The company unlocked MXN 1.1 billion in productivity savings to reinvest in growth initiatives, including product innovation and distribution expansion [1] - The cash-conversion cycle remained healthy at 107 days, indicating effective management of working capital [1] - Despite a -2.2% decline in Mexico sell-out during Q4, underlying consumer demand was confirmed to be resilient [1]

Core Viewpoint - A class action lawsuit has been announced against Snowflake Inc. for securities fraud, involving purchasers of Class A common stock between June 27, 2023, and February 28, 2024, with the opportunity for investors to serve as lead plaintiffs [1]. Group 1: Lawsuit Details - The lawsuit claims that during the class period, Snowflake's management made positive statements about business performance while failing to disclose significant negative impacts on consumption and revenues due to product efficiency gains and pricing strategies [1]. - Investors who purchased Snowflake Class A common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The Rosen Law Firm, which is leading the lawsuit, has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors in the past [1]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [1]. - A lead plaintiff must be appointed by April 27, 2026, to represent the interests of the class members in the litigation [1]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they may choose to remain absent from the class [1].

Core Viewpoint - Nutex Health, Inc. is set to release its Annual Report for the fiscal year ended December 31, 2025, on March 5, 2026, and will hold an earnings conference call on March 6, 2026, to discuss financial performance and business updates [1]. Company Overview - Nutex Health, Inc. is a physician-led integrated healthcare delivery system with 27 micro hospitals and outpatient departments across 12 states [1]. - The company operates two divisions: a Hospital Division, which includes micro-hospitals and specialty hospitals, and a Population Health Management Division, which manages provider networks [1]. Financial Reporting - The Annual Report on Form 10-K will be filed after market close on March 5, 2026, with a press release summarizing financial results issued on the same day [1]. - The earnings conference call is scheduled for March 6, 2026, at 9:30 a.m. CT, where the company will provide insights into its financial performance [1]. Conference Call Details - Participants can join the conference call by dialing 1-877-407-9208 or 1-201-493-6784 [1]. - A transcript and recording of the call will be available on the company's website under "Investor Materials" following the event [1].

Oak-Eagle AcquireCo, Inc. Announces Pricing Terms for the Previously Announced Tender Offers and Consent Solicitations for Any and All of Electronic Arts Inc.'s 1.850% Senior Notes Due 2031 and 2.950% Senior Notes Due 2051 [Accessibility Statement] Skip NavigationWILMINGTON, Del., Feb. 25, 2026 /PRNewswire/ -- Oak-Eagle AcquireCo, Inc. (the "Offeror") announced today the pricing for the previously announced offers to purchase for cash (each, a "Tender Offer" and, together, the "Tender Offers") any and all o ...

Tri-County Financial Group, Inc. Reports Fourth Quarter and Year-to-Date 2025 Financial Results [Accessibility Statement] Skip NavigationMENDOTA, Ill., Feb. 25, 2026 /PRNewswire/ -- Tri-County Financial Group, Inc. (the "Company") (OTCQX: TYFG) today announced financial results for the fourth quarter of 2025.Net income for the fourth quarter of 2025 was $3.9 million ($1.64 per share), compared to $2.4 million ($1.00 per share) during the fourth quarter of 2024. Net income was $13.7 million ($5.73 per share) ...

TETRA TECHNOLOGIES, INC. ANNOUNCES FOURTH-QUARTER AND STRONG FULL-YEAR 2025 RESULTS AND PROVIDES UPDATE ON STRATEGIC INITIATIVES [Accessibility Statement] Skip NavigationSPRING, Texas, Feb. 25, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and twelve months ended December 31, 2025.Fourth-Quarter 2025 Financial Highlights- Adjusted free cash flow was $3.1 million and base business adjusted free cash flow was exceptionally strong ...

New Jersey American Water Invests Over $781 Million in 2025 Statewide Infrastructure Upgrades [Accessibility Statement] Skip NavigationStrengthening System Reliability and Water Quality for CustomersCAMDEN, N.J., Feb. 25, 2026 /PRNewswire/ -- New Jersey American Water today announced that it invested more than $781 million in [water and wastewater system improvements] across the Garden State in 2025 - a significant increase from the approximately $520 million invested in 2024. This year-over-year growth ref ...